Predictivity and sensitivity of animal models of arthritis

Autoimmunity Reviews

Volumn 8, Issue 1, 2008, Pages 73-75

  Di Paola, Rosanna ^a   Cuzzocrea, Salvatore ^a,b  

^a IRCCS CENTRO NEUROLESI BONINO PULEJO   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

Chemokines; Rheumatoid arthritis; T lymphocyte activity

Indexed keywords

ACETYLSALICYLIC ACID; ADALIMUMAB; AURANOFIN; CELECOXIB; CORTICOSTEROID; CYCLOSPORIN; DEXTROPROPOXYPHENE; DICLOFENAC; FLURBIPROFEN; HYDROXYCHLOROQUINE; IBUPROFEN; INDOMETACIN; KETOPROFEN; LEFLUNOMIDE; MELOXICAM; METHOTREXATE; METHYLPREDNISOLONE; NAPROXEN; OXAPROZIN; PARACETAMOL; PENICILLAMINE; PHENYLBUTAZONE; PIROXICAM; PREDNISONE; SALAZOSULFAPYRIDINE; SULINDAC; TOLMETIN; TRAMADOL; UNINDEXED DRUG; VALDECOXIB;

ADJUVANT ARTHRITIS; AVRIDINE INDUCED ARTHRITIS; BACTERIAL ARTHRITIS; CARTILAGE OLIGOMERIC MATRIX PROTEIN INDUCED ARTHRITIS; COLLAGEN INDUCED RHEUMATOID ARTHRITIS; DISEASE MODEL; EXPERIMENTAL MODEL; EXPERIMENTAL MOUSE; EXPERIMENTAL RAT; GENETIC MANIPULATION; MOUSE STRAIN; NONHUMAN; OIL INDUCED ARTHRITIS; PATHOGENESIS; PREDICTION; PRISTANE INDUCED ARTHRITIS; PROTEOGLYCAN INDUCED ARTHRITIS; REVIEW; RHEUMATOID ARTHRITIS; SENSITIVITY ANALYSIS; SPRAGUE DAWLEY RAT; STAPHYLOCOCCUS AUREUS; STREPTOCOCCAL CELL WALL INDUCED ARTHRITIS; WISTAR RAT;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; DISEASE MODELS, ANIMAL; MICE; PREDICTIVE VALUE OF TESTS; RATS; SENSITIVITY AND SPECIFICITY; SPECIES SPECIFICITY;

EID: 54549107887     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2008.07.029     Document Type: Review

References (22)

1. Feldmann M., Brennan F.M., and Maini R.N. Rheumatoid arthritis. Cell 85 (1996) 307-310
2. Carlsen S., Hansson A.S., Olsson H., Heinegard D., and Holmdahl R. Cartilage oligomeric matrix protein (COMP)-induced arthritis in rats. Clin Exp Immunol 114 (1998) 477-484
3. Wilder R.L., Remmers E.F., Kawahito Y., Gulko PS., Cannon GW., and Griffiths MM. Genetic factors regulating experimental arthritis in mice and rats. Curr Dir Autoimmun 1 (1999) 121-165
4. Vingsbo C., Jonsson R., and Holmdahl R. Avridine-induced arthritis in rats; a T cell-dependent chronic disease influenced both by MHC genes and by non-MHC genes. Clin Exp Immunol 99 (1995) 359-363
5. Holmberg J., Tuncel J., Yamada H., Lu S., Olofsson P., and Holmdahl R. Pristane, a non-antigenic adjuvant, induces MHC class II-restricted, arthritogenic T cells in the rat. J Immunol 176 2 (2006) 1172-1179
6. Kleinau S., Erlandsson H., Holmdahl R., and Klareskog L. Adjuvant oils induce arthritis in the DA rat. I. Characterization of the disease and evidence for an immunological involvement. J Autoimmun 4 (1991) 871-880
7. Wilder R.L. Streptococcal cell-wall-induced arthritis in rats: an overview. Int J Tissue React 10 (1988) 1-5
8. Courtenay J.S., Dallman M.J., Dayan A.D., Martin A., and Mosedale B. Immunisation against heterologous type II collagen induces arthritis in mice. Nature 283 (1980) 666-668
9. Glant T.T., Finnegan A., and Mikecz K. Proteoglycan-induced arthritis: immune regulation, cellular mechanisms, and genetics. Crit Rev Immunol 23 (2003) 199-250
10. Bremell T., Abdelnour A., and Tarkowski A. Histopathological and serological progression of experimental Staphylococcus aureus arthritis. Infect Immun 60 (1992) 2976-2985
11. Nocton J.J., and Steere A.C. Lyme disease. Adv Intern Med 40 (1995) 69-117
12. Holmdahl R., Andersson E.C., Andersen C.B., Svejgaard A., and Fugger L. Transgenic mouse models of rheumatoid arthritis. Immunol Rev 169 (1999) 161-173
13. Cepeda M.S., Camargo F., Zea C., and Valencia L. Tramadol for osteoarthritis: a systematic review and metaanalysis. J Rheumatol 34 (2007) 543-555
14. Miller D.R. Combination use of nonsteroidal antiinflammatory drugs. Drug Intell Clin Pharm 15 (1981) 3-7
15. Small R.E. Diclofenac sodium. Clin Pharm 8 (1989) 545-558
16. Frampton J.E., and Keating G.M. Celecoxib: a review of its use in the management of arthritis and acute pain. Drugs 67 (2007) 2433-2472
17. Evens R.P. Drug therapy reviews: antirheumatic agents. Am J Hosp Pharm 36 (1979) 622-633
18. Tanaka Y. [Corticosteroids for treatment of rheumatoid arthritis]. Nippon rinsho 63 Suppl 1 (2005) 468-471
19. Niehues T., Winterhalter S., Zierhut M., et al. [EBM analysis: classic DMARDs (disease-modifying antirheumatic drugs) and immunosuppressants in arthritis and uveitis]. Klin Monatsbl Augenheilkd 224 (2007) 520-525
20. Dale J., Alcorn N., Capell H., and Madhok R. Combination therapy for rheumatoid arthritis: methotrexate and sulfasalazine together or with other DMARDs. Nat Clin Pract Rheumatol 3 8 (2007) 450-458
21. Alonso-Ruiz A., Pijoan J.I., Ansuategui E., et al. Tumor necrosis factor alpha drugs in rheumatoid arthritis: systematic review and metaanalysis of efficacy and safety. BMC Musculoskelet Disord 9 (2008) 52
22. Fleischmann R., Stern R., and Iqbal I. Anakinra: an inhibitor of IL-1 for the treatment of rheumatoid arthritis. Expert Opin Biol Ther 4 8 (2004) 1333-1344